Company handles distribution of 'niche' blood, chemotherapy and specialty products
BDI Pharma (Columbia, SC) is in the final stages of construction and licensing of a DC near the Dallas-Fort Worth airport, the better to serve its customers of immunoglobulin, albumin, vaccines, chemotherapy products and other specialty pharmaceuticals. The facility, the company’s second national DC, more than doubles its warehousing capacity and ultimately will manage 40% of its shipments, according to a company statement. There is also room for future expansion.
BDI Pharma provides basic wholesaling services as well as sales and marketing services for manufacturers and reimbursement services for patients, seeking to act as a commercialization extension of its biopharma suppliers.
Earlier this year, it expanded its cold-chain storage capacity and built new offices near its Columbia, SC headquarters; at that time it announced a 40% increase in sales over the previous year.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.